Excellent news - might take a while to get all the testing etc done but once completed, it will prove very popular methinks :t_up:
Have had a stake in this company from almost the beginning - has been a long haul but they are getting there...
Printable View
Excellent news - might take a while to get all the testing etc done but once completed, it will prove very popular methinks :t_up:
Have had a stake in this company from almost the beginning - has been a long haul but they are getting there...
Pay off could be pretty incredible if widely adopted across GPs, although that's obviously many years and several clinical trials away. People say that medicine moves fast but high technology can take a very long time to filter through unfortunately, even after the trials. Just another possible string in their bow - currently keeping more than busy enough with existing customers and applications.
So youve right clicked on the link, a window opens up with choices, and one left clicks on "copy link"
Then goes to sharetrader reply space, right clicks and window comes up, left click on "Paste "and presto.
PharmaZen_half_year_result_2019_USX.pdf
Testing?
https://www.usx.co.nz/uploads/paperc...pdf?1579047886
JT That's incredible..Thank you.
Good to see Prof. Kate McGrath appointed Independent Director. She is currently Deputy Vice-Chancellor of University of Technology Sydney. Previously had senior appointments at Victoria University, MacDiamard Institute, and Callaghan Innovation.
And interesting to see Syft Technlogies units are being used in cancer detection research by Imperial College London, Otago University, and Callaghan Institution. Early days, but good to see the advancement of this technology into the medical sphere.
It is all progress.
[QUOTE=percy;785843]SIFT-MS technology drives simplification of bowel cancer screening
15 January 2020 Press Release
Firm: Syft Technologies Limited
Security: Syft Tech Ords
Documents:
Syft_bowel_cancer_trials.pdf
This should be very interesting.Warning it will take years,but I don't think anyone will miss having a colonoscopy.?[/QU
Interesting timing after issuing those shares for something that has being trialed for 2 years
Interesting timing after issuing those shares for something that has being trialed for 2 years
SYFT Quarterly Newsletter shows further progress. The FY result soon - hopefully will be very good news.